Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state.
暂无分享,去创建一个
Satoshi Imaizumi | Masahiro Fujino | Sadashiva S Karnik | Y. Kiya | S. Miura | S. Imaizumi | K. Saku | M. Fujino | S. Karnik | T. Kanazawa | Shin-ichiro Miura | Yoshihiro Kiya | Takanori Kanazawa | Yoshino Matsuo | Keijiro Saku | Yoshino Matsuo
[1] J. Thevelein,et al. Glucose and sucrose act as agonist and mannose as antagonist ligands of the G protein-coupled receptor Gpr1 in the yeast Saccharomyces cerevisiae. , 2004, Molecular cell.
[2] X. P. Liu,et al. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction. , 1996, Biochemistry.
[3] S. Miura,et al. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111). , 1998, Biochemistry.
[4] K. Catt,et al. International union of pharmacology. XXIII. The angiotensin II receptors. , 2000, Pharmacological reviews.
[5] H. Ohta,et al. Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure. , 2001, Hypertension research : official journal of the Japanese Society of Hypertension.
[6] S. Miura,et al. Molecular analysis of the structure and function of the angiotensin II type 1 receptor. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[7] David S. Goodsell,et al. Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4 , 1996, J. Comput. Aided Mol. Des..
[8] R. Alonso,et al. pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry. , 2001, Journal of pharmaceutical and biomedical analysis.
[9] Keita Noda,et al. “Network Leaning” as a Mechanism of Insurmountable Antagonism of the Angiotensin II Type 1 Receptor by Non-peptide Antagonists* , 2004, Journal of Biological Chemistry.
[10] S. Miura,et al. Constitutive Activation of Angiotensin II Type 1 Receptor Alters the Orientation of Transmembrane Helix-2* , 2002, The Journal of Biological Chemistry.
[11] R. Graham,et al. Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation. , 2002, Biochemistry.
[12] H Weinstein,et al. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.
[13] S. Miura,et al. TM2-TM7 Interaction in Coupling Movement of Transmembrane Helices to Activation of the Angiotensin II Type-1 Receptor* , 2003, The Journal of Biological Chemistry.
[14] P. Corvol,et al. Effect of Reduced Angiotensin-Converting Enzyme Gene Expression and Angiotensin-Converting Enzyme Inhibition on Angiotensin and Bradykinin Peptide Levels in Mice , 2004, Hypertension.
[15] S. Kudoh,et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II , 2004, Nature Cell Biology.
[16] Dennis A Dougherty,et al. Cation-pi interactions in ligand recognition and catalysis. , 2002, Trends in pharmacological sciences.
[17] D. A. Dougherty,et al. From ab initio quantum mechanics to molecular neurobiology: a cation-pi binding site in the nicotinic receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[19] Cation-π versus OH-π Interactions in Proteins: A Density Functional Study , 2000 .
[20] L. Gnudi,et al. Interaction of Angiotensin Ii and Mechanical Stretch on Vascular Endothelial Growth Factor Production by Human Mesangial Cells , 2022 .
[21] S. Miura,et al. Role of Aromaticity of Agonist Switches of Angiotensin II in the Activation of the AT1 Receptor* , 1999, The Journal of Biological Chemistry.
[22] S. Karnik,et al. The Docking of Arg2 of Angiotensin II with Asp281 of AT1 Receptor Is Essential for Full Agonism (*) , 1995, The Journal of Biological Chemistry.
[23] G. Flesch,et al. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man , 1997, European Journal of Clinical Pharmacology.
[24] I. Komuro,et al. Molecular Mechanism Underlying Inverse Agonist of Angiotensin II Type 1 Receptor* , 2006, Journal of Biological Chemistry.
[25] J. Gallivan,et al. Can lone pairs bind to a pi system? The water...hexafluorobenzene interaction. , 1999, Organic letters.
[26] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[27] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[28] S. Miura,et al. Constitutively Active Homo-oligomeric Angiotensin II Type 2 Receptor Induces Cell Signaling Independent of Receptor Conformation and Ligand Stimulation* , 2005, Journal of Biological Chemistry.
[29] R. Graham,et al. Tetrazole and Carboxylate Groups of Angiotensin Receptor Antagonists Bind to the Same Subsite by Different Mechanisms (*) , 1995, The Journal of Biological Chemistry.
[30] E. Cesarman,et al. Erratum: G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[31] L. Pardo,et al. Linking agonist binding to histamine H1 receptor activation , 2005, Nature chemical biology.